「Yellow fever」の版間の差分
Vaccipedia.admin (トーク | 投稿記録) |
Vaccipedia.admin (トーク | 投稿記録) |
||
| 11行目: | 11行目: | ||
===Epidemiology across countries=== | ===Epidemiology across countries=== | ||
| − | *A systematic review found incidences of YF across African countries were quite heterogenous (I<sup>2</sup>=99.4%) and failed to quantitative synthesis for meta-analysis. | + | *A systematic review found incidences of YF across African countries were quite heterogenous (I<sup>2</sup>=99.4%) as <1:100,000 in Nigeria to 10,350:100,000 in Ghana and failed to quantitative synthesis for meta-analysis. |
{{quote | {{quote | ||
|content=Nwaiwu, A. U., Musekiwa, A., Tamuzi, J. L., Sambala, E. Z., & Nyasulu, P. S. (2021). The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. BMC Infectious Diseases, 21(1), 1–11. https://doi.org/10.1186/s12879-021-06728-x | |content=Nwaiwu, A. U., Musekiwa, A., Tamuzi, J. L., Sambala, E. Z., & Nyasulu, P. S. (2021). The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. BMC Infectious Diseases, 21(1), 1–11. https://doi.org/10.1186/s12879-021-06728-x | ||
2023年9月7日 (木) 13:27時点における版
| Navigation Menu |
| General issues of Vaccine | |||||||
|---|---|---|---|---|---|---|---|
|
| General issues of Travel med. | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Immunology | |||||||
|---|---|---|---|---|---|---|---|
|
| Epi & Stats | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Virus | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| COVID-19 | |||||
|---|---|---|---|---|---|
|
| Bacteria | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Rickettsia | |||||
|---|---|---|---|---|---|
|
| Protozoa | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Fungi | |||||||
|---|---|---|---|---|---|---|---|
|
| Nematode (roundworm) | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| Trematode (fluke, distoma) | |||||||
|---|---|---|---|---|---|---|---|
|
| Cestode (tapeworm) | ||||||
|---|---|---|---|---|---|---|
|
| Medical Zoology | ||||||||
|---|---|---|---|---|---|---|---|---|
|
目次
Epidemiology
Due to non-specific acute febrile illness in its early stage including substantial number of asymptomatic cases, there are limitations to define the true incidence and case fatality rate of YF.
Case definitions
- WHO suggests case definitions to survey YF with suspected case as Any person with acute onset of fever, with jaundice appearing within 14 days of onset of the first symptoms.
|
World Health Organization. (2022). Yellow Fever Outbreak Toolbox. https://www.who.int/emergencies/outbreak-toolkit/disease-outbreak-toolboxes/yellow-fever-outbreak-toolbox |
Epidemiology across countries
- A systematic review found incidences of YF across African countries were quite heterogenous (I2=99.4%) as <1:100,000 in Nigeria to 10,350:100,000 in Ghana and failed to quantitative synthesis for meta-analysis.
|
Nwaiwu, A. U., Musekiwa, A., Tamuzi, J. L., Sambala, E. Z., & Nyasulu, P. S. (2021). The incidence and mortality of yellow fever in Africa: a systematic review and meta-analysis. BMC Infectious Diseases, 21(1), 1–11. https://doi.org/10.1186/s12879-021-06728-x |
Epidemiology according to severity and Case fatality rate
- A mathematical estimation using Bayesian model showed probability of asymptomatic infection, mild disease and severe disease as 55%, 33% and 12%, respectively, as well as case fatality rate among severe disease as 47%, but the 11 studies authors collected for the study were highly heterogeneous.
|
Johansson, M. A., Vasconcelos, P. F. C., & Staples, J. E. (2014). The whole iceberg: Estimating the incidence of yellow fever virus infection from the number of severe cases. Transactions of the Royal Society of Tropical Medicine and Hygiene, 108(8), 482–487. https://doi.org/10.1093/trstmh/tru092 |
- A systematic review and meta-analysis concluded from 14 articles that case fatality rate of YF among severe disease is 39% (95%CI 31-47).
|
Servadio, J. L., Muñoz-Zanzi, C., & Convertino, M. (2021). Estimating case fatality risk of severe Yellow Fever cases: systematic literature review and meta-analysis. BMC Infectious Diseases, 21(1), 1–12. https://doi.org/10.1186/s12879-021-06535-4 |
transmission
- sylvatic cycle
- savannah cycle only in Africa
- urban cycle
- reason why YF doesn't exist in Asia is unknown
clinical features
- 3-6 days incubation
- infection phase
- remission phase
- most patients ended with remission phase
- intoxication phase
prevention
- new XRX-001 vaccine may be safer